Proceedings of the Fourth International Meeting of the International Society for title], September 1991, Urbino, Italy. The most recent applications of, and developments in, this technology are presented in 42 articles which address such topics as the methods and procedures for preparing resealed e

Until recently the only biomedical use of erythrocytes was in transfusion medicine to restore a normal oxygen delivery. The development of a technology that permits one to open and reseal erythrocytes has dramatically changed this perspective. Currently, a number of teams have shown that engineered erythrocytes can behave as circulating bioreactors for the degradation of toxic metabolites or the inactivation of xenobiotics, as drug delivery systems, as carriers of antigens of vaccinal interest, and in many others biomedical applications. The technology of opening and resealing the...